Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Midori ISHII"'
Autor:
Daniel Ballmer, William Carter, Jolien J. E. van Hooff, Eelco C. Tromer, Midori Ishii, Patryk Ludzia, Bungo Akiyoshi
Publikováno v:
Open Biology, Vol 14, Iss 6 (2024)
Faithful transmission of genetic material is crucial for the survival of all organisms. In many eukaryotes, a feedback control mechanism called the spindle checkpoint ensures chromosome segregation fidelity by delaying cell cycle progression until al
Externí odkaz:
https://doaj.org/article/fc51c75b5ea24df384d7b5ae11810b0e
Autor:
Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Midori Ishii, Yoko Azusawa, Yasuharu Hamano, Hidetaka Eguchi, Masami Arai, Jun Ando, Miki Ando
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24801- (2024)
Background: Acute graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with significant morbidity and mortality, and efficacy of currently available therapeutics are limited. Acute
Externí odkaz:
https://doaj.org/article/2568fad0772844d3aee047e5688cdf1f
Autor:
Midori ISHII, Maki KAMOSHITA, Yoshihiro KURIHARA, Kazuaki MATSUMURA, Suong-Hyu HYON, Junya ITO, Naomi KASHIWAZAKI
Publikováno v:
The Journal of Reproduction and Development, Vol 69, Iss 1, Pp 53-55 (2022)
The vitrification of zygotes is important for their use as donors for generating genome-edited mice. We previously reported the successful vitrification of mouse zygotes using carboxylated ε-poly-L-lysine (COOH-PLL). However, this vitrification solu
Externí odkaz:
https://doaj.org/article/e425303e091340d59f3cecb20ef25df4
Autor:
Bungo Akiyoshi, Midori Ishii
Publikováno v:
Wellcome Open Research, Vol 7 (2022)
Targeted protein degradation is an invaluable tool in studying the function of proteins. Such a tool was not available in Trypanosoma brucei, an evolutionarily divergent eukaryote that causes human African trypanosomiasis. Here, we have adapted deGra
Externí odkaz:
https://doaj.org/article/aef02abb12f34e6292fc5fb2b1bba11d
Autor:
Bungo Akiyoshi, Midori Ishii
Publikováno v:
Wellcome Open Research, Vol 7 (2022)
Targeted protein degradation is an invaluable tool in studying the function of proteins. Such a tool was not available in Trypanosoma brucei, an evolutionarily divergent eukaryote that causes human African trypanosomiasis. Here, we have adapted deGra
Externí odkaz:
https://doaj.org/article/f44ec073b8d645a0bae059055a3ffbe3
Autor:
Kazuo Ohara, Shintaro Kinoshita, Jun Ando, Yoko Azusawa, Midori Ishii, Sakiko Harada, Yoichiro Mitsuishi, Tetsuhiko Asao, Ken Tajima, Taketsugu Yamamoto, Fumiyuki Takahashi, Norio Komatsu, Kazuhisa Takahashi, Miki Ando
Publikováno v:
Biochemistry and Biophysics Reports, Vol 27, Iss , Pp 101089- (2021)
Small cell lung cancer (SCLC) is a type of high-grade neuroendocrine carcinoma. It initially responds to chemotherapy but rapidly becomes chemoresistant and it is highly proliferative. The prognosis in SCLC is poor. We have established a novel SCLC c
Externí odkaz:
https://doaj.org/article/e0a028390c53421a8a8de93541f119e7
Autor:
Shintaro Kinoshita, Miki Ando, Jun Ando, Midori Ishii, Yoshiki Furukawa, Osamu Tomita, Yoko Azusawa, Shuichi Shirane, Yoshihito Kishita, Yukiko Yatsuka, Hidetaka Eguchi, Yasushi Okazaki, Norio Komatsu
Publikováno v:
Heliyon, Vol 7, Iss 8, Pp e07804- (2021)
Trio-next generation sequencing is useful to identify undiagnosed inherited diseases. We have attended a patient with trigenic ADH5/ALDH2/ADGRV1 pathogenic variants, which caused two distinct diseases, myelodysplastic syndrome and Usher syndrome. Who
Externí odkaz:
https://doaj.org/article/4ada943c12bf44c887392ad2ff3f2fa3
Autor:
Kei Sano, Yoshiyuki Suehara, Taketo Okubo, Keita Sasa, Taisei Kurihara, Keisuke Akaike, Daisuke Kubota, Tomoaki Torigoe, Nobuhiko Hasegawa, Midori Ishii, Yasuhiro Nakamura, Youngji Kim, Tatsuya Takagi, Kazuo Kaneko, Takuo Hayashi, Tsuyoshi Saito
Publikováno v:
Journal of Orthopaedic Surgery, Vol 28 (2020)
Purpose: Giant cell tumor of bone (GCTB) is a local aggressive bone tumor, histologically classified as intermediate malignancy. Recently, the RANKL inhibitor, denosumab, was developed as a novel and effective treatment option for GCTB. Since the ris
Externí odkaz:
https://doaj.org/article/3ca92a4666e84041aebf413dcf4b86d4
Autor:
Miki Ando, Jun Ando, Satoshi Yamazaki, Midori Ishii, Yumi Sakiyama, Sakiko Harada, Tadahiro Honda, Tomoyuki Yamaguchi, Masanori Nojima, Koichi Ohshima, Hiromitsu Nakauchi, Norio Komatsu
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
Functionally rejuvenated induced pluripotent stem cell (iPSC)-derived antigen-specific cytotoxic T lymphocytes (CTL) are expected to be a potent immunotherapy for tumors. When L-asparaginase-containing standard chemotherapy fails in extranodal natura
Externí odkaz:
https://doaj.org/article/d3751404669b4739a4a9bb8215ec7b7a
Autor:
Kenta Mukaihara, Yoshiyuki Suehara, Shinji Kohsaka, Keisuke Akaike, Yu Tanabe, Daisuke Kubota, Midori Ishii, Tsutomu Fujimura, Saiko Kazuno, Taketo Okubo, Tatsuya Takagi, Takashi Yao, Kazuo Kaneko, Tsuyoshi Saito
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148401 (2016)
Giant cell tumors of bone (GCTB) are locally aggressive osteolytic bone tumors. Recently, some clinical trials have shown that denosumab is a novel and effective therapeutic option for aggressive and recurrent GCTB. This study was performed to invest
Externí odkaz:
https://doaj.org/article/33b5da174f11452695524ec1fe58f34c